August 7, 2026

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Biotech Star with 50% Potential Upside

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a burgeoning name in the biotechnology sector, has captured the attention of investors with its promising pipeline of monoclonal antibody therapeutics..

STAAR Surgical Company (STAA) Stock Analysis: Unveiling a 24.95% Potential Upside

For investors keen on the healthcare sector, STAAR Surgical Company (NASDAQ: STAA) presents an intriguing opportunity. Specializing in the design and manufacture of phakic implantable lenses,..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Promising 151% Potential Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering player in the biotechnology sector, is capturing investor attention with its significant growth potential. Currently valued at approximately $948.97..

Verastem, Inc. (VSTM) Stock Analysis: 151.69% Potential Upside in Biotech Space

Verastem, Inc. (NASDAQ: VSTM), a promising player in the biotechnology sector, is capturing the attention of investors with its potential for substantial upside. As a development-stage..

AxoGen, Inc. (AXGN) Stock Analysis: A Promising 20% Upside in the Medical Devices Sector

AxoGen, Inc. (NASDAQ: AXGN), a leading player in the healthcare sector specializing in medical devices for peripheral nerve regeneration, is drawing attention from investors with its..

Autolus Therapeutics plc (AUTL) Stock Analysis: Biotechnology Innovator with 333% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company based in London, UK, is capturing investor attention with its innovative approach to T cell therapies for..

Kamada Ltd. (KMDA) Stock Analysis: Unpacking an 82% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents an intriguing opportunity. Specializing in plasma-derived protein therapeutics, this Israeli-based company..

Celcuity Inc. (CELC) Investor Outlook: Biotechnology Innovator with 75% Potential Upside

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, has captured the attention of investors with its promising drug development pipeline and a striking potential upside of..

Growth Potential for Personalis, Inc. (PSNL): A Look at its 30% Revenue Surge

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the Diagnostics & Research industry within the Healthcare sector, is drawing investor attention with its promising revenue growth..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a 43% Upside Potential in Biotechnology

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising outlook in the biotechnology sector. Headquartered in New..

Neuropace, Inc. (NPCE) Stock Analysis: A 45% Potential Upside Awaits Investors

Neuropace, Inc. (NASDAQ: NPCE) is drawing significant attention in the healthcare sector, specifically within the innovative realm of medical devices. Known for its pioneering RNS System,..

Tyra Biosciences (TYRA) Stock Analysis: A Biotech with 92% Upside Potential

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company, has captured investor attention with its promising pipeline and remarkable upside potential. With an impressive projected upside..

RxSight, Inc. (RXST) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector

RxSight, Inc. (NASDAQ: RXST) is a company that’s drawing attention within the medical devices industry, particularly for its innovative approach in enhancing vision post-cataract surgery. As..

Prothena Corporation plc (PRTA) Stock Analysis: 149% Potential Upside Ignites Investor Interest

Prothena Corporation plc (NASDAQ: PRTA), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline of novel therapies aimed at treating..

Standard BioTools Inc. (LAB) Stock Report: Evaluating a Potential 93% Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB), a player in the healthcare sector specializing in medical devices, has captured investor interest with its significant potential upside of nearly..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a 7.75% Upside Potential

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates a network of general acute care hospitals throughout the United States. Headquartered..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring a 67.87% Potential Upside for Investors

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company based in New Haven, Connecticut, is making waves in the healthcare sector with its innovative approach to protein..

EyePoint, Inc. (EYPT) Stock Analysis: Unpacking a 218% Potential Upside in the Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) is a notable player in the biotechnology industry, focusing on innovative treatments for retinal diseases. With its proprietary Durasert E technology, EyePoint..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 676% Potential Upside in Biotech

Cel-Sci Corporation (NASDAQ: CVM) is a clinical-stage biotechnology firm that has captured the attention of investors with its promising pipeline and significant upside potential. Specializing in..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring the 221% Potential Upside

Definitive Healthcare Corp. (DH) has been capturing investor interest with its healthcare commercial intelligence platform, a key player in the burgeoning health information services industry. Headquartered..

Search

Funds

August 7, 2026

Search

Funds

August 7, 2026

FTSE 100

Funds